Low expression of SHP-2 is associated with less favorable prostate cancer outcomes (Q85563932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Low expression of SHP-2 is associated with less favorable prostate cancer outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

David Ulmert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Helena Tassidis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Karin Jirström

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Anders Bjartell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Pirkko Härkönen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Anette Gjörloff Wingren

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

29 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

637-642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192641%20AND%20SRC:MED&resulttype=core&format=json

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

19 February 2020

cites work

1 reference

12 December 2020

Protein tyrosine phosphatases and the immune response

1 reference

12 December 2020

Immunohistochemical analyses of phosphatases in childhood B-cell lymphoma: lower expression of PTEN and HePTP and higher number of positive cells for nuclear SHP2 in B-cell lymphoma cases compared to controls

1 reference

12 December 2020

Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer

1 reference

12 December 2020

The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury

1 reference

12 December 2020

Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.

1 reference

12 December 2020

The tyrosine phosphatase Shp2 (PTPN11) in cancer.

1 reference

12 December 2020

SHP-2 phosphatase regulates DNA damage-induced apoptosis and G2/M arrest in catalytically dependent and independent manners, respectively

1 reference

12 December 2020

Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia

1 reference

12 December 2020

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

12 December 2020

Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation

1 reference

12 December 2020

Hormone resistance in prostate cancer

1 reference

12 December 2020

PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases

1 reference

12 December 2020

Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells

1 reference

12 December 2020

Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype

1 reference

12 December 2020

Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells

1 reference

12 December 2020

A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival

1 reference

12 December 2020

The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer

1 reference

12 December 2020

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

1 reference

12 December 2020